Thursday, 10 July 2008
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR
Fine
The FINE blog keeps you up-to-date on the pharmaceutical fine chemical and custom manufacturing sector. The weekly FINE Newsletter gives senior pharmaceutical fine chemical and custom manufacturing leaders a weekly summary of the key news stories and trends for the sector. The FINE Newsletter and blog focus on coverage of companies in the pharmaceutical fine chemical custom manufacturing sector, without forgetting key news from their customers in the pharma industry.
Subscribe
To receive the newsletter, each week, please subscribe.
Advertising
|
|
|
|
||
| Read this FREE online! Full Book | PDF Summary | Podcast | ||
Blog Archive
-
▼
2008
(457)
-
▼
July
(41)
- US Senator Sherrod Brown requests Merck outsourcin...
- BASF reported looking at takeover targets: WR Grac...
- Call for FDA overhaul
- Weylchem starts large-scale Grignard reagent manuf...
- Almac has broken ground at the site of its US head...
- Net profit at Piramal Healthcare rose by 57% to Rs...
- Cobra Biomanufacturing has extended its manufactur...
- Lonza predicts weaker H2, expands Hopkinton site
- SAFC record sales, expects slower growth
- Helsinn's Birex Pharmaceuticals facility in Dublin...
- FDA to send workers overseas by end 2009
- Johnson Matthey sees increased fine chemicals sale...
- Q2 sales rise for Albemarle's fine chemicals
- AMRI has doubled its laboratory capacity in Singapore
- Roche offers $43.7bn for remainder of Genentech
- Aesica to cut jobs following contract loss
- Teva Pharmaceuticals will acquire generics rival B...
- FDA changes rules to exempt phase I drugs from som...
- Angel Biotechnology has received a milestone payme...
- Exchange rates hit Jubilant Organosys as profits f...
- Angel Biotechnoogy will develop pre-GMP manufactur...
- Lonza has extended its GS Expression System licens...
- Ranbaxy faces US probe over quality
- Jubilant Organosys has began a three-year pre-clin...
- Angel Biotechnology's loss for 2007 was £1.2m, one...
- Ashland to acquire Hercules for $2.6bn
- Lonza in development deal with Novartis
- Ranbaxy Fine Chemicals eyes US acquisition
- Inspectors collaborate
- Dow to acquire Rohm & Haas for $18.8bn
- Penn acquired by Minakem
- Rentschler to expand biomanufacturing and exit pharma
- Aquapharm in Dr Reddy's licensing deals
- Albemarle to manufacture ibuprofen for Dr Reddy's
- Potential buyer pulls out of Pfizer Little Island ...
- BASF chemist awarded 2008 Siegfried Medal for chir...
- Pfizer expected to bid for Ranbaxy, top Daiichi bi...
- World Bank group invests in Hikal
- Progen Pharmaceuticals has "spun-out" its manufact...
- Lonza has completed its acquisition of Amaxa and h...
- Lonza commits to stem cells
-
▼
July
(41)
Technorati
Copyright ©2007, 2008 FINE. All rights reserved.
No comments:
Post a Comment